University of Virginia; Kinesiology Labs
Charlottesville, Virginia, 22903, United States
NCT Number: NCT05131217
This study will analyze the influence of acute bout exercise intensities (continuous moderate and HIIT) on middle cerebral artery velocity (MCAv) to identify which intensity elicits the greatest increase in CBF in older adults (65+ yrs). Additionally, this study will help verify positive correlations between MCAv and cognitive function. These findings are important in determining the optimal exercise prescription for increased resilience against the age-related cognitive degradation.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Charlottesville, Virginia, 22903, United States
With an increasingly aging population, it is paramount that we further understand the changes that occur during aging, especially those which contribute to cognitive decline. Evidence shows that cognitive function is closely linked to brain blood flow. When comparing cerebral blood flow (CBF) between old and young individuals, older adults appear to have lower baseline levels of CBF. One of the principle determinants of CBF is CO2. Since exercise results in rises in CO2 production, changes in CBF can be monitored. Older adults appear to have diminished changes in CBF compared to younger individuals during moderate intensity exercise. This then leads to the idea that older adults may need a greater exercise stimulus (i.e. HIIT) to see these changes in CBF. However, the effects of HIIT on CBF in older adults is largely unstudied.
Purpose: To analyze the acute influence of HIIT on middle cerebral artery velocity (MCAv) in older adults, and to verify the positive association between MCAv and cognitive function.
Experimental Design: Recruiting 16 healthy adults age 65 and older. The study will require each participant to report to 4 visits: a screening visit, a control, a moderate intensity exercise bout, and a high intensity exercise bout. The order of the experimental visits will be randomized to each subject, and exercise bouts will be work-matched. During the experimental visits, MCAv, end-tidal CO2, MAP, and HR will be measured continuously. Vascular measures such as pulse wave analysis and pulse wave velocity will be taken pre- and post-exercise. Additionally, blood flow through the internal carotid artery and cognitive measures (n-back test) will be measured and administered pre-exercise, and at 15 mins, 30 mins, and 45 mins post-exercise. A two-way repeated measures ANOVA will be used to determine significant differences for time (pre vs. post measures) x condition (control/moderate/HIIT).
Results: In the process of collecting data.
Implications: If the study is successful in its findings, this could change how exercise is prescribed to older adults. It could also lead to the question regarding if a greater exercise stimulus (i.e. SIT) may be even more beneficial for these individuals.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this experimental intervention subjects will cycle continuously at moderate intensity (VO2 corresponding to lactate threshold) until a 200 kcal equivalent energy expenditure is reached.
In this experimental invention subjects will alternate between 1 minute of high intensity cycling (watts corresponding to 85% VO2peak) and 1 minute of low intensity cycling (watts corresponding to 35-40% VO2peak) until a 200 kcal equivalent energy expenditure is reached.
Other names: HIIT
In this intervention placebo, subjects will lay down on a flat, soft surface for 30 minutes in a dimly light room. They will not be allowed to use any electronic devices or read during this time to avoid potentially influencing continuous data recording.
Other names: Rest
Time frame: Measured continuously over the course of each experimental session (i.e. 2-3 hours)
Blood flow velocity measured in the Middle Cerebral Artery via Transcranial Doppler probe secured to the right temporal window.
Time frame: 4 individual measurements taken during each experimental session with each session lasting up to about 3 hours. 1 pre-intervention measurement and 3 post-intervention measurements spaced at least 15min apart
Measured via n-back test (2-back); Subject's will be presented a sequence of letters (25 of them from a base set of 15 letters) one-by-one and will have 3 seconds to indicate whether the letter they see currently matches the letter from 2 frames ago. If there is no match, then they do not need to respond.They will complete three rounds each with a different sequence. Accuracy score (%) = correct inputs/# of stimuli, averaged across 3 blocks.
Time frame: 4 individual measurements taken during each experimental session with each session lasting up to about 3 hours. 1 pre-intervention measurement and 3 post-intervention measurements spaced at least 15min apart
Measured via Ultrasound; diameter will be measured as the peak of the pulse wave
Time frame: 4 individual measurements taken during each experimental session with each session lasting up to about 3 hours. 1 pre-intervention measurement and 3 post-intervention measurements spaced at least 15min apart
Measured via Ultrasound; velocity will be assessed at the peak of each pulse wave
Time frame: Measured continuously over the course of each experimental session (i.e. 2-3 hours)
Measured via three-lead ECG
Time frame: Measured continuously over the course of each experimental session (i.e. 2-3 hours)
Measured via Capnograph; connected nasal cannulas are placed in the nostrils and respiration will be assessed continuously
Time frame: Measured continuously over the course of each experimental session (i.e. 2-3 hours)
Measured via Finger photoplethysmography (Non-Invasive Blood Pressure; NIBP), pressure cuffs on the subjects fingers will take continual blood pressure readings via continual inflation and deflation
Time frame: 4 individual measurements taken during each experimental session with each session lasting up to about 3 hours. 1 pre-intervention measurement and 3 post-intervention measurements spaced at least 15min apart
Measured via Pulse Wave Analysis; a SphygmoCor device probe will be held on carotid artery and pulse wave will be analyzed
Time frame: 4 individual measurements taken during each experimental session with each session lasting up to about 3 hours. 1 pre-intervention measurement and 3 post-intervention measurements spaced at least 15min apart
Measured via SphygmoCor; distances between brachial artery and femoral artery will be taken for calibration, cuffs at the brachial and femoral arteries will inflate and SphygmoCor will take pulse wave measurements
Time frame: 4 individual measurements taken during each experimental session with each session lasting up to about 3 hours. 1 pre-intervention measurement and 3 post-intervention measurements spaced at least 15min apart
Measured via Ultrasound; diameter will be measured during both systole and diastole
University of Virginia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05706181
Aging Well, Body Temperature Changes
Fort Worth, Texas, United States
View Trial DetailsNCT05380180
Aging, Aging Well
Champaign, Illinois, United States
View Trial DetailsNCT05908539
Aging Well, Behavior
Hong Kong
View Trial DetailsNCT06219148
Aging Well, Brain Diseases
Lexington, Kentucky, United States
View Trial Details